Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
23.71
-1.11 (-4.47%)
Nov 17, 2026, 3:04 PM CST

SHE:301015 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
1,8522,1371,4671,3441,0481,276
Trading Asset Securities
357.75264.4644.9927.6227.2240.77
Cash & Short-Term Investments
2,2092,4021,5121,3721,0751,317
Cash Growth
7.41%58.81%10.23%27.63%-18.38%15.32%
Accounts Receivable
1,5421,9602,2162,4642,2321,943
Other Receivables
59.276.44161.58214.7844.4341.34
Receivables
1,6012,0362,3772,6792,2771,984
Inventory
1,181895.57927.75861.67650.1623.85
Prepaid Expenses
----0.60.55
Other Current Assets
574.61383.94293.35205.94255.48165.91
Total Current Assets
5,5665,7185,1115,1184,2584,092
Property, Plant & Equipment
927.16885.47810.65672.15432.99225.75
Long-Term Investments
1,057901.78742.62263.95181.57151.71
Goodwill
112.49112.49112.49107.60.695.96
Other Intangible Assets
254.86227.52227.59140.0956.7728.65
Long-Term Deferred Tax Assets
102.9186.7858.176.5736.6532.85
Long-Term Deferred Charges
69.7476.740.7334.318.018.3
Other Long-Term Assets
61.9103.89.434.555.6158.02
Total Assets
8,1528,1127,1136,4175,0304,603

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
1,0171,2191,1631,072990.3845.76
Accrued Expenses
99.33308.27229.97206.1211.14138.26
Short-Term Debt
2,3891,9321,099513.021,1651,189
Current Portion of Long-Term Debt
90.1750.6943.4161.44--
Current Portion of Leases
-34.2627.8720.7827.3415.42
Current Income Taxes Payable
78.4854.6464.78101.4733.9932.52
Current Unearned Revenue
135.28146.65118.5297.892.48113.78
Other Current Liabilities
158.26232.03512.32319.0683.5466.32
Total Current Liabilities
3,9673,9773,2582,3922,6042,401
Long-Term Debt
1,3061,2531,113771.93--
Long-Term Leases
100.57109.6102.5687.41145.3422.21
Long-Term Unearned Revenue
12.3212.9111.4313.6--
Long-Term Deferred Tax Liabilities
12.2717.3418.3933.541.135.85
Other Long-Term Liabilities
--5---
Total Liabilities
5,3995,3704,5083,2982,7502,429

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
525.62525.62525.62525.61525.1525.1
Additional Paid-In Capital
40.7616.31-653.47411.61418.31
Retained Earnings
1,7641,8251,7501,6101,3641,212
Comprehensive Income & Other
92.8196.6798.91101.631.652.11
Total Common Equity
2,4232,4632,3752,8912,3022,157
Minority Interest
330.28278.7229.76228.4-22.1116.76
Shareholders' Equity
2,7532,7422,6053,1192,2802,174
Total Liabilities & Equity
8,1528,1127,1136,4175,0304,603

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
3,8853,3802,3851,4551,3381,226
Net Cash (Debt)
-1,676-978.05-872.59-82.51-262.7190.77
Net Cash Growth
------
Net Cash Per Share
-3.19-1.83-1.61-0.15-0.500.18
Filing Date Shares Outstanding
525.62525.62525.62519.55525.1525.1
Total Common Shares Outstanding
525.62525.62525.62519.55525.1525.1
Working Capital
1,5991,7401,8532,7271,6541,691
Book Value Per Share
4.614.694.525.564.384.11
Tangible Book Value
2,0562,1232,0352,6432,2452,123
Tangible Book Value Per Share
3.914.043.875.094.274.04
Buildings
-608.41504.28464.74206.13206.13
Machinery
-544.22450.97338.9691.278.02
Construction In Progress
-67.69152.26143.2980.58.78